IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
InflaRx N.V.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.45+0.13 (+9.85%)
Close on Oct 19, 2026
InflaRx statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | InflaRx | Industry median |
|---|---|---|
| Market Cap | €93.65M | €911.72M |
| Enterprise Value | €77.63M | €858.97M |
| PS Ratio | 3192.93 | 7.36 |
| PB Ratio | 13.06 | 1.21 |
| P/TBV Ratio | 13.06 | 2.50 |
Enterprise value
| Measure | InflaRx | Industry median |
|---|---|---|
| EV / Sales | 2646.68 | 3.57 |
Income (trailing twelve months)
| Measure | InflaRx | Industry median |
|---|---|---|
| Revenue | €29.33K | €447.40M |
| Gross Profit | -€7.24M | €1.08B |
| Pretax Income | -€45.62M | -€49.18M |
| EPS (Diluted) | -0.68 EUR | -0.61 EUR |
Margins
| Measure | InflaRx | Industry median |
|---|---|---|
| Gross Margin | -24677.9% | 42.8% |
| Pretax Margin | -155540.0% | -36.6% |
Growth
| Measure | InflaRx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -82.3% | 1.99% |
Balance sheet
| Measure | InflaRx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | €16.02M | €291.68M |
| Net Cash (Debt) | €16.02M | €87.54M |
| Net Cash Per Share | 0.22 EUR | 1.09 EUR |
| Equity (Book Value) | €7.17M | €952.53M |
| Book Value Per Share | 0.10 EUR | 5.36 EUR |
| Tangible Book Value | €7.17M | €21.84M |
| Working Capital | €40.65M | €121.78M |
Financial position
| Measure | InflaRx | Industry median |
|---|---|---|
| Current Ratio | 4.13 | 2.81 |
| Quick Ratio | 1.23 | 1.23 |
Cash flow (trailing twelve months)
| Measure | InflaRx | Industry median |
|---|---|---|
| Operating Cash Flow | -€35.31M | -€35.31M |
Efficiency
| Measure | InflaRx | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.32 |
| Inventory Turnover | 1.05 | 1.33 |
Dividends and yields
| Measure | InflaRx | Industry median |
|---|---|---|
| Buyback Yield | -24.5% | -11.1% |
| Shareholder Yield | -24.5% | -11.1% |
Shares
| Measure | InflaRx | Industry median |
|---|---|---|
| Shares Outstanding | 72,292,900 | 105,361,000 |
| Shares Change (YoY) | 14.2% | 6.28% |
| Float | 67,948,200 | 78,574,400 |
| Shares Held by Insiders | 6.01% | 9.05% |
Taxes
| Measure | InflaRx | Industry median |
|---|---|---|
| Income Tax | €12.28K | €1.53M |
Scores
| Measure | InflaRx | Industry median |
|---|---|---|
| Altman Z-Score | -4.58 | 1.02 |
Calculated by StockData from InflaRx's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.